---
title: "Retension Pharmaceuticals Names Robert Wong Chief Accounting Officer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302859015.md"
description: "Retension Pharmaceuticals appointed Robert Wong as Vice President and Chief Accounting Officer, effective November 2, 2026. Wong previously held the same role at Cytokinetics (2019-2024) and most recently served as VP of Accounting at The Save Mart Companies."
datetime: "2026-10-23T10:04:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302859015.md)
  - [en](https://longbridge.com/en/news/302859015.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302859015.md)
generator: "portal-rs"
---

# Retension Pharmaceuticals Names Robert Wong Chief Accounting Officer

-   Retension Pharmaceuticals appointed Robert Wong vice president and chief accounting officer on October 21, 2026, effective November 2, 2026. \* Wong most recently served as vice president of accounting at The Save Mart Companies, overseeing accounting, finance, tax and treasury. \* He previously served as Cytokinetics’ vice president and chief accounting officer from 2019 to 2024. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Retension Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-111794), on October 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RTSN.US](https://longbridge.com/en/quote/RTSN.US.md)
- [CYTK.US](https://longbridge.com/en/quote/CYTK.US.md)

## Related News & Research

- [Retension Pharma director Franklin M. Berger acquires 10,000 common shares for $120,000](https://longbridge.com/en/news/301760599.md)
- [Retension Pharmaceuticals adopts amended and restated bylaws ahead of IPO close](https://longbridge.com/en/news/301750965.md)
- [Coca-Cola Executive Vice President Nancy Quan Reports Sale of $1.47 Million in Common Shares](https://longbridge.com/en/news/305501694.md)
- [Visa says card enumeration fuels more than $1 billion in annual global fraud losses](https://longbridge.com/en/news/305494235.md)
- [Anthropic’s Valuation Target Has Slipped From $2 Trillion to Under $1.5 Trillion. Here’s Why](https://longbridge.com/en/news/305493732.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**